 "Dr Reddy's Laboratories nears lifetime high")
Dr Reddy’s Laboratories trading higher by 2.4% at Rs 4,284 on the BSE after the drug maker said that the promoter buying shares of the company through open market.
The stock hit an intra-day high of Rs 4,308, is less than 1% away from its lifetime high of Rs 4,337 touched on August 14 this year.
“Dr. Reddy’s Holdings, the promoter group company acquired 6,500 shares of the company from open market through stock exchange on September 22, 2015,” Dr Reddy’s Laboratories said in a BSE filing.
Post acquisition, Dr. Reddy’s Holdings stake in the company increased to 23.35% from 23.34% earlier, it added.
Dr. Reddy’s Holdings, which held 23.31% stake in Dr Reddy’s Laboratories as of June 30, 2015, has bought 66,250 of the company through open market in July-September quarter, data shows.
Since June 30, the stock has rallied 21% from Rs 3,551 compared to 3% decline in the S&P BSE Sensex.
The stock hit an intra-day high of Rs 4,308, is less than 1% away from its lifetime high of Rs 4,337 touched on August 14 this year.
“Dr. Reddy’s Holdings, the promoter group company acquired 6,500 shares of the company from open market through stock exchange on September 22, 2015,” Dr Reddy’s Laboratories said in a BSE filing.
Post acquisition, Dr. Reddy’s Holdings stake in the company increased to 23.35% from 23.34% earlier, it added.
Dr. Reddy’s Holdings, which held 23.31% stake in Dr Reddy’s Laboratories as of June 30, 2015, has bought 66,250 of the company through open market in July-September quarter, data shows.
Since June 30, the stock has rallied 21% from Rs 3,551 compared to 3% decline in the S&P BSE Sensex.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%